SCN2A: Biological Roles and Therapeutics Strategies 

• Gene Information: Human SCN2A, located on chromosome 2, encodes the pore-forming α-subunit of voltage-gated sodium channel NaV1.2, a core neuronal ion channel. The NaV1.2 protein comprises four homologous domains, and each domain contains six transmembrane segments. 
• Protein Expression: NaV1.2 is predominantly expressed throughout the central nervous system, with the highest abundance in excitatory neurons. 
• Signaling Pathway: NaV1.2 mediates rapid Na+ influx across the neuronal membrane. This process initiates and propagates neuronal action potentials, thereby governing synaptic transmission and neural circuit excitability. 
• Therapeutic Inhibition: SCN2A serves as a critical therapeutic target for multiple neurodevelopmental disorders with opposite pathological mechanisms: For gain-of-function (GoF) variants causing early-onset developmental and epileptic encephalopathy (DEE): Sodium channel blockers and SCN2A expression suppressors exert prominent therapeutic benefits to alleviate recurrent seizures; For loss-of-function (LoF) variants associated with autism spectrum disorder (ASD): Upregulating NaV1.2 expression or activating channel function is the rational therapeutic direction.

SCN2A 

• The exons 1-27 of mouse Scn2a gene that encode the whole molecule (ATG to STOP codon), including 3’UTR were replaced by human counterparts in B-hSCN2A mice. 
• The promoter and 5’UTR region of the mouse gene are also replaced. The mouse Scn2a gene transcription and translation will be disrupted.

• Human SCN2A mRNA was detectable only in heterozygous B-hSCN2A mice but not in wild-type mice.

Strain specific analysis of SCN2A mRNA expression in wild-type C57BL/6JNifdc mice and heterozygous B-hSCN2A mice by RT-PCR. Cortex RNA were isolated from wild-type C57BL/6JNifdc mice (+/+) and heterozygous B-hSCN2A mice (H/+), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human SCN2A primers. Mouse Scn2a mRNA was detectable in wild-type mice and heterozygous B-hSCN2A mice. Human SCN2A mRNA was detectable only in heterozygous B-hSCN2A mice but not in wild-type mice, and human sequences were confirmed via Sanger sequencing.